Piedmont Investment Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,992
| Closed | -$381K | – | 1031 |
|
|
2019
Q1 | $381K | Buy |
3,992
+230
| +6% | +$22K | 0.02% | 677 |
|
|
2018
Q4 | $266K | Buy |
3,762
+125
| +3% | +$8.84K | 0.01% | 793 |
|
|
2018
Q3 | $311K | Buy |
3,637
+229
| +7% | +$19.6K | 0.01% | 767 |
|
|
2018
Q2 | $395K | Buy |
3,408
+338
| +11% | +$39.2K | 0.02% | 528 |
|
|
2018
Q1 | $248K | Buy |
+3,070
| New | +$248K | 0.01% | 639 |
|